Breathing carbon dioxide to uncover hidden stroke risks in kids
NCT ID NCT04157179
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aims to learn how blood flow and oxygen use in the brain change as children grow, especially in those with sickle cell disease who are at risk for stroke. Researchers will use MRI scans and have participants breathe in small amounts of carbon dioxide to see how well their brain blood vessels expand. The study includes healthy children and adults as well as those with sickle cell disease, and may also involve blood tests and thinking assessments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Carbon dioxide
- What this could lead to
- If successful, this could help doctors better understand how blood flow and oxygen supply affect brain development and stroke risk in children with sickle cell disease.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health, and results may not lead to new therapies for years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University of St. Louis
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Co-Designed support help parents embrace sickle cell care?
- Can community hospitals in zambia master severe disease care?
- A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?
- Can a phone app keep teens on track with sickle cell treatment?
- A common amino acid may calm sickle cell pain crises — a trial puts it to the test
- A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease